Toggle light / dark theme

In America, at least 17 people a day die waiting for an organ transplant. But instead of waiting for a donor to die, what if we could someday grow our own organs?

Last week, six years after NASA announced its Vascular Tissue Challenge, a competition designed to accelerate research that could someday lead to artificial organs, the agency named two winning teams. The challenge required teams to create thick, vascularized human organ tissue that could survive for 30 days.

The two teams, named Winston and WFIRM, both from the Wake Forest Institute for Regenerative Medicine, used different 3D-printing techniques to create lab-grown liver tissue that would satisfy all of NASA’s requirements and maintain their function.

“We did take two different approaches because when you look at tissues and vascularity, you look at the body doing two main things,” says Anthony Atala, team leader for WFIRM and director of the institute.

The two approaches differ in the way vascularization—how blood vessels form inside the body—is achieved. One used tubular structures and the other spongy tissue structures to help deliver cell nutrients and remove waste. According to Atala, the challenge represented a hallmark for bioengineering because the liver, the largest internal organ in the body, is one of the most complex tissues to replicate due to the high number of functions it performs.

HOMA calculator: https://www.omnicalculator.com/health/homa-ir.

Papers referenced in the video:
Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice.
https://pubmed.ncbi.nlm.nih.gov/24175087/

Glucose regulation and oxidative stress in healthy centenarians.
https://pubmed.ncbi.nlm.nih.gov/12543271/

Distribution of blood glucose and prevalence of diabetes among centenarians and oldest-old in China: based on the China Hainan Centenarian Cohort Study and China Hainan Oldest-old Cohort Study.

Experts predict that we’ll be able to live up to 20% longer over the next 100 years. Here’s how humans are trying to live forever. Andrea Schmitz and Benji Jones Apr 3, 2019, 12:00 PM @ These potential treatments for aging could unlock cures to a range of age-related illnesses, from cancer to heart disease – Charlotte Hu Aug 20, 2018, 1:21 PM @ Animals that defy the rules of aging — like naked mole rats — could help scientists unravel the secrets to longevity – Charlotte Hu Aug 15, 2018, 2:54 PM @ Everything you thought you knew about aging is wrong – Erin Brodwin Apr 27, 2016, 12:13 PM *© 2021 Insider Inc. @ Other very important information, images, YouTube Videos (Ray Kurzweil – Physical Immortality – 3 de jan. de 2017 & Ray Kurzweil + Disruptive Technologies and Dangerous Ideas – 5 de dez. de 2017), websites, social networks and links.

“Well, it has to do with our technology,” said Hoge. “We use something called messenger RNA, or mRNA for short. It’s really just an instruction molecule, kind of like a software program for your cells. It just sends instructions about what the virus looks like to your immune system. So just like a software program, or a Word document, we can simply edit something, change it, and then manufacture it very, very quickly.”

He makes it sound so easy, but it’s taken more than a decade of research, and many technological hurdles. Now, the company has some big plans. “We’ve had an incredible year using messenger RNA to fight a pandemic,” Hoge said. “But we think we’re just starting in the infectious disease space, And so, there’s a large number of other vaccines we’re bringing forward.”

Moderna’s research pipeline includes everything from an HIV vaccine, to heart disease treatments, to vaccines for different kinds of cancer, including lymphoma and melanoma.

Nanobots, tiny nano-sized robots and vehicles that can navigate through blood vessels to reach the site of a disease could be used to deliver drugs to tumours that are otherwise difficult to treat.

Once injected or swallowed, most drugs rely upon the movement of body fluids to find their way around the body. It means that some types of disease can be difficult to treat effectively in this way.

One aggressive type of brain tumour known as glioblastoma, for example, kills hundreds of thousands of people a year. But because it produces finger-like projections into a patient’s brain tissue that damage the blood vessels around them, it is hard for drugs to reach the tumour site.

Hello everybody! In this episode, we interview Felix Werth, a trully hero of the rejuvenation field: in 2015 he created a party in Germany to defend more investments in our field, and his party is contesting the general elections in the country on September 26th 2021! However, he needs our help right now, since his party has until July 19th to collect enough signatures to participate in 14 German states covering 98% of the country’s population. So be sure to check the interview and the party’s website (https://parteifuergesundheitsforschung.de) to see how you can help.


In this episode of ImmortaliCast, Nicolas and Nina talk to Felix Werth, the founder and leader of the German Party for Health Research, a party with a single issue: 10% of the government budget should be spent on research for the development of treatments of age-related diseases. The party will contest the German general elections of September 26th 2021.

Party for Health Research website: https://parteifuergesundheitsforschung.de.

This product came out months ago with some shocking numbers as to effect. But those effects were in mice tests. 10–20% increase in lifespan and 55% increase in healthspan. It is AKG, Rejuvant, it’s a product you can buy now. There will be a part 2 of this interview so I hope to hear about human data.


Here we present an interview with Tom Weldon the founder and CEO of Ponce de Leon Health, which makes Rejuvant a Calcium AKG based supplement. In this video Tom talks through the process and reasons for selecting CaAKG. He also talks about some of the other results that they found in their tests, especially with respect to mixing different supplements and their combined effects.

This it part 1 of a two part series. In part 2 we talk about his personal experience and on going clinical trials. With that let me start the interview.

There are Sirt6 activators on the market, but since we are not seeing any major news about results I would question their value.


SPONSOR: Longevity. Technology — https://www.longevity.technology/?utm_source=SSS&utm_medium=…aign=Sirt6

Sirtuins are highly conserved proteins that are involved in a variety of important cellular processes such as DNA repair, metabolism and circadian rhythms. The mammalian sirtuins (SIRT1-7) are a family of proteins that carry out NAD+-dependent protein deacylation and mono-ADP-ribosylation. These modifications on proteins can influence their stability, localisation within a cell and activity.

CHICAGO, IL — Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since 2004.

In future-looking research, Northwestern University Feinberg School of Medicine scientists have identified a novel target for a drug to treat SARS-CoV-2 that also could impact a new emerging coronavirus.

“God forbid we need this, but we will be ready,” said Karla Satchell, professor of microbiology-immunology at Feinberg, who leads an international team of scientists to analyze the important structures of the virus. The Northwestern team previously mapped the structure of a virus protein called nsp16, which is present in all coronaviruses. This new study provides critical information that could aid drug development against future coronaviruses as well as SARS-CoV-2.